Anticoagulant therapy is indicated in many clinical situations. The handling of vitamin K antagonists (VKA) is difficult and their therapeutic range is narrow, requiring close biological monitoring of INR. Introduction of VKA is a particularly critical period. Algorithms for initiation of oral anticoagulant therapy have been proposed but they are generally designed for warfarin, which has a longer half life as compared to acenocoumarol. In this article, algorithms for the prescription of acenocoumarol are proposed, taking into account the patient's age, weight and initial Quick value. The goal of these algorithms, combined with frequent monitoring of INR, is to limit the bleeding risk during the introduction of anticoagulant therapy
Thrombosis is the process of a blood clot forming inside a blood vessel, obstructing blood flow. Ora...
UNLABELLED: Essentials We developed a new algorithm to optimize vitamin K antagonist dose finding. V...
This thesis suggests that bitherapy with a new oral anticoagulant and clopidogrel should now be the ...
Oral anticoagulant therapy is initiated in most hospitals in The Netherlands by clinicians who routi...
Oral anticoagulant therapy is initiated in most hospitals in The Netherlands by clinicians who routi...
INTRODUCTION: Vitamin K antagonists of the coumarin type are widely used oral anticoagulants.OBJECTI...
BACKGROUND: The large variability in dose requirement of vitamin K antagonists is well known. For wa...
Abstract Background Hemorrhagic events are frequent in patients on treatment with antivitamin-K oral...
There is a strong association between genetic polymorphisms and the acenocoumarol dosage requirement...
Vitamin K antagonists (VKAs) are used off-label in pediatric patients to treat or prevent thromboemb...
<div><p>There is a strong association between genetic polymorphisms and the acenocoumarol dosage req...
Background In a retrospective study we have developed a model which determines the dose of acenocoum...
In this thesis we aimed to further explore the relevance of dosing algorithms for VKAs compared to s...
[Optimizing the management of patients under vitamin K antagonists: Why and how?] Although several n...
Prospective validation of two algorithms for the initiation of phenprocoumon treatment.; Inpatients ...
Thrombosis is the process of a blood clot forming inside a blood vessel, obstructing blood flow. Ora...
UNLABELLED: Essentials We developed a new algorithm to optimize vitamin K antagonist dose finding. V...
This thesis suggests that bitherapy with a new oral anticoagulant and clopidogrel should now be the ...
Oral anticoagulant therapy is initiated in most hospitals in The Netherlands by clinicians who routi...
Oral anticoagulant therapy is initiated in most hospitals in The Netherlands by clinicians who routi...
INTRODUCTION: Vitamin K antagonists of the coumarin type are widely used oral anticoagulants.OBJECTI...
BACKGROUND: The large variability in dose requirement of vitamin K antagonists is well known. For wa...
Abstract Background Hemorrhagic events are frequent in patients on treatment with antivitamin-K oral...
There is a strong association between genetic polymorphisms and the acenocoumarol dosage requirement...
Vitamin K antagonists (VKAs) are used off-label in pediatric patients to treat or prevent thromboemb...
<div><p>There is a strong association between genetic polymorphisms and the acenocoumarol dosage req...
Background In a retrospective study we have developed a model which determines the dose of acenocoum...
In this thesis we aimed to further explore the relevance of dosing algorithms for VKAs compared to s...
[Optimizing the management of patients under vitamin K antagonists: Why and how?] Although several n...
Prospective validation of two algorithms for the initiation of phenprocoumon treatment.; Inpatients ...
Thrombosis is the process of a blood clot forming inside a blood vessel, obstructing blood flow. Ora...
UNLABELLED: Essentials We developed a new algorithm to optimize vitamin K antagonist dose finding. V...
This thesis suggests that bitherapy with a new oral anticoagulant and clopidogrel should now be the ...